Just had a quick look and the first thing that jumps out is the...

Just had a quick look and the first thing that jumps out is the decline in margin. Having said that I guess we should be grateful that at least it would appear that the company is profitable with the Australian dollar at US$0.70 when previous management couldn't even make money when the dollar was at parity or better. Its my guess that all inventory would now have been purchased at this level so margins should be at least stable going forward.
It seems obvious that the Medivet business was a poor investment and is going nowhere fast - at least without significant further investment. I think that the company made the right decision in getting out when they did. I'm not sure if we will ever see anything come from the earn-out provisions on the sale agreement to Delk.
No mention of their move into infection control in the half year but I see any further moves into this area has only having positive impacts. Looking for further updates now from the company on what their plans might be without the dead weight of Medivet.
IMHO, DYOR etc